Cronos Group Inc Market Cap ($1.32 Billion)
Market Cap & Net Worth: Cronos Group Inc (CRON)
Cronos Group Inc market cap. Cronos Group Inc (TO:CRON) has a market capitalization of $1.32 Billion (CA$1.82 Billion) as of November 5, 2026. Listed on the TO stock exchange, this Canada-based company holds position #7473 globally and #234 in its home market, demonstrating a 2.15% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cronos Group Inc's stock price CA$4.76 by its total outstanding shares 382893267 (382.89 Million). Also see Cronos Group Inc cash flow conversion for how efficiently the company converts equity into cash flow.
Cronos Group Inc Market Cap History (2015–2026)
Cronos Group Inc market cap history from 2015 to 2026. Data shows growth from $87.25 Million to $1.32 Billion (26.98% CAGR). Check Cronos Group Inc stock price for real-time trading data and today's change.
Cronos Group Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cronos Group Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Cronos Group Inc to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
6.81x
Cronos Group Inc's market cap is 6.81 times its annual revenue
Latest Price to Earnings (P/E) Ratio
19.50x
Cronos Group Inc's market cap is 19.50 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $87.25 Million | $2.46 Million | $278.73K | 35.50x | 313.02x |
| 2016 | $409.93 Million | $409.79K | -$880.23K | 1000.35x | N/A |
| 2017 | $2.70 Billion | $3.11 Million | -$1.47 Million | 867.28x | N/A |
| 2018 | $3.98 Billion | $13.09 Million | -$23.37 Million | 304.17x | N/A |
| 2019 | $2.76 Billion | $23.16 Million | $1.14 Billion | 119.22x | 2.43x |
| 2020 | $2.45 Billion | $46.57 Million | -$72.90 Million | 52.58x | N/A |
| 2021 | $1.38 Billion | $64.02 Million | -$392.81 Million | 21.54x | N/A |
| 2022 | $952.81 Million | $87.54 Million | -$170.26 Million | 10.88x | N/A |
| 2023 | $767.23 Million | $87.03 Million | -$73.79 Million | 8.82x | N/A |
| 2024 | $800.47 Million | $117.50 Million | $41.04 Million | 6.81x | 19.50x |
Competitor Companies of CRON by Market Capitalization
Companies near Cronos Group Inc in the global market cap rankings as of November 5, 2026. Also see balance sheet size of Cronos Group Inc for a full breakdown of the balance sheet.
Key companies related to Cronos Group Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Cronos Group Inc (2015–2026)
Market capitalization of Cronos Group Inc from 2015 to today. Between 2015 and today, Cronos Group Inc's market cap moved from $87.25 Million to $ 1.32 Billion, with a yearly change of 26.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$1.32 Billion | +32.22% |
| 2025 | CA$997.12 Million | +24.57% |
| 2024 | CA$800.47 Million | +4.33% |
| 2023 | CA$767.23 Million | -19.48% |
| 2022 | CA$952.81 Million | -30.92% |
| 2021 | CA$1.38 Billion | -43.67% |
| 2020 | CA$2.45 Billion | -11.33% |
| 2019 | CA$2.76 Billion | -30.67% |
| 2018 | CA$3.98 Billion | +47.64% |
| 2017 | CA$2.70 Billion | +558.11% |
| 2016 | CA$409.93 Million | +369.84% |
| 2015 | CA$87.25 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Cronos Group Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.32 Billion USD |
| MoneyControl | $1.32 Billion USD |
| MarketWatch | $1.32 Billion USD |
| marketcap.company | $1.32 Billion USD |
| Reuters | $1.32 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cronos Group Inc
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.